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Abstract A patient with a history of adenoid cystic carci-
noma of the nasal cavity presented himself with bone pain
and an elevated PSA level. On suspicion of metastatic
prostate cancer a 68Ga-PSMA PET-CT was performed.
The PET-CT showed numerous lung and non-sclerotic
bone metastasis. Biopsy of a bone metastasis was per-
formed and pathology showed adenoid cystic carcinoma
instead of prostate cancer. Immunohistochemical PSMA
staining of the primary tumour showed intense PSMA ex-
pression in adenoid cystic carcinoma tumour cells.
Because of the high PSMA expression of adenoid cystic
carcinoma, 68Ga-PSMA PET-CT might be a promising im-
aging modality for this malignancy.
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Fig. 1 Sagittal (a) and axial (b) fused PET-CT images and coronal
maximum intensity projection of 68GA-PSMA PET (c) showing intense
PSMA binding in adenoid cyst ic carc inoma metas tases .
Immunohistochemistry of the primary tumour showed intense PSMA
expression mainly in adenoid cystic carcinoma tumour cells (d, arrows)
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